| RS2544690519 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690565 |
CHD3
|
Health Risk |
Pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2544690643 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2544690691 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690717 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544690768 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544691950 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544692049 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544693381 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544693552 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544695286 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544695896 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2544695974 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant tumor of breast, Fanconi anemia complementation group J |
| RS2544696032 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2544696268 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2544696416 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2544696439 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2544696743 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2544696786 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2544697127 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2544698040 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2544698078 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2544698218 |
NXN
|
Health Risk |
Pathogenic |
— |
| RS2544699266 |
KATNIP
|
Health Risk |
Likely pathogenic |
Joubert syndrome 26, Joubert syndrome 26 |
| RS2544700193 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700259 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700348 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700366 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544700568 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700730 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544700783 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700816 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544700880 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544700934 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701027 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544701053 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701059 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701125 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701178 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544701247 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701268 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701332 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701461 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701474 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544701563 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544701569 |
NF1
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Juvenile myelomonocytic leukemia |
| RS2544701595 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701804 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544701917 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544705725 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
Joubert syndrome 7, Joubert syndrome 7 |
| RS2544705900 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, CHD3-related disorder |
| RS2544706126 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544706912 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544707873 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2544708386 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544710305 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2544710685 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544711045 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544711824 |
ODAD4
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2544712716 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544712802 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544712917 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult (ADPKD) |
| RS2544713742 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544715201 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544715242 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544715496 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544715545 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544716328 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544717084 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2544717535 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544717657 |
USB1
|
Health Risk |
Likely pathogenic |
— |
| RS2544717844 |
COL13A1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2544717941 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544718286 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544718564 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544718591 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544718715 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544718720 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544718723 |
SPECC1
|
Health Risk |
Likely pathogenic |
Myoepithelial tumor, Myoepithelial tumor |
| RS2544718731 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544718812 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544718880 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544718919 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544718974 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544719014 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544719104 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544719118 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544719176 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544719194 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS2544719215 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544719457 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544726550 |
USB1
|
Health Risk |
Pathogenic |
— |
| RS2544729773 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544729882 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544729897 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544729906 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544730117 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544730146 |
PKD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Polycystic kidney disease |
| RS2544730274 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2544730498 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |